4//SEC Filing
Elliott Russell P. 4
Accession 0001178913-18-002611
CIK 0001606645other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 5:20 PM ET
Size
5.4 KB
Accession
0001178913-18-002611
Insider Transaction Report
Form 4
Elliott Russell P.
VP Drug Development
Transactions
- Sale
Ordinary Shares
2018-10-01$5.81/sh−142$825→ 12,442 total
Footnotes (1)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. This sale is mandated by the Issuer's non-discretionary policy that requires the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Documents
Issuer
Foamix Pharmaceuticals Ltd.
CIK 0001606645
Entity typeother
Related Parties
1- filerCIK 0001727807
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 5:20 PM ET
- Size
- 5.4 KB